Medpace Holdings (MEDP) Shares Outstanding (Diluted Average) (2020 - 2026)

Medpace Holdings has reported Shares Outstanding (Diluted Average) for 7 years, with the latest figure at $29.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 7.16% year-over-year to $29.0 million; the trailing twelve-month figure through Mar 2026 stood at $29.0 million (down 7.16% YoY), and the FY2025 full-year result was $29.5 million, down 7.77% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $29.0 million, down from $29.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $36.4 million in Q1 2022, with the low at $28.8 million in Q3 2025.
• Historically, Shares Outstanding (Diluted Average) has averaged $32.0 million across 5 years, with a median of $32.0 million in 2024.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) slipped 11.57% — and 2024, when it increased 1.49%.
• Medpace Holdings' Shares Outstanding (Diluted Average) stood at $33.7 million in 2022, then dropped by 5.43% to $31.8 million in 2023, then rose by 0.54% to $32.0 million in 2024, then fell by 7.77% to $29.5 million in 2025, then dropped by 1.91% to $29.0 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $29.0 million (Q1 2026), $29.5 million (Q4 2025), and $28.8 million (Q3 2025), per Business Quant data.